Catalyst Wire Dossier Catalyst Wire Dossier

Synercid

quinupristin/dalfopristin · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Synercid, covering 2012-05-25 to 2012-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients [Phase 3]

See pricing